- Home
- SLN vs EOSE Comparison
SLN vs EOSE Comparison
Compare SLN & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLN | EOSE |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLN | EOSE |
|---|---|---|
| Price | $19.76 | $1.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $19.75 | $5.84 |
| AVG Volume (30 Days) | 4.4M | ★ 23.9M |
| Earning Date | 11-20-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $559,000.00 | ★ $114,203,000.00 |
| Revenue This Year | N/A | $168.84 |
| Revenue Next Year | $131.31 | $87.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 631.79 |
| 52 Week Low | $4.19 | $1.59 |
| 52 Week High | $19.87 | $19.65 |
Technical Indicators
Market Signals| Indicator | SLN | EOSE |
|---|---|---|
| Relative Strength Index (RSI) | 78.21 | 40.43 |
| Support Level | $13.01 | N/A |
| Resistance Level | $19.87 | $4.45 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 58.49 | 35.81 |
Price Performance
Historical ComparisonAbout SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector.